Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

IMITREX 100 MG TABLET

sumatriptan
$72.5312per EA
High Outlier

Strength

100 mg/1

Manufacturer

GlaxoSmithKline LLC

NDC

00173073701

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SUMATRIPTAN SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA020132

On Market Since

12/19/2003

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price History

1W

0.0%

1M

+0.1%

3M

+0.3%

6M

+0.2%

1Y

-0.1%

3Y

+2.5%

5Y

+8.8%

All

+121.7%

Generic Alternatives

Save up to 99%

1 alternative • Same active ingredient

SUMATRIPTAN SUCC 100 MG TABLET
Generic
64980066236•Rising Pharma Holdings Inc.
$0.4322
Save 99%

Related Drugs

Same classification

MAXALT MLT 10 MG TABLET
Brand
78206014301•Organon LLC
$44.3130
per EA
MAXALT 10 MG TABLET
Brand
78206014201•Organon LLC
$44.4765
per EA
RELPAX 40 MG TABLET
Brand
00049234005•Roerig
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036856•Viatris Specialty LLC
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036896•Viatris Specialty LLC
$77.1492
per EA
RELPAX 20 MG TABLET
Brand
00049233045•Roerig
$77.3165
per EA
RELPAX 20 MG TABLET
Brand
58151036756•Viatris Specialty LLC
$77.3165
per EA
TOSYMRA 10 MG NASAL SPRAY
Brand
70792081261•Tonix Medicines, Inc.
$108.1537
per EA
ZOMIG 2.5 MG NASAL SPRAY
Brand
64896008312•Amneal Pharmaceuticals LLC
$108.5647
per EA
ZOMIG 5 MG NASAL SPRAY
Brand
64896008412•Amneal Pharmaceuticals LLC
$109.5042
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy